This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Academia Sinica. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New Taipei, TW (2019)
- Taipei, TW (2022)
Company Filing History:
Years Active: 2019-2022
Title: Maria Karmella Apaya: Innovator in Cancer Treatment and Plant Extracts
Introduction
Maria Karmella Apaya is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the fields of cancer treatment and plant-based pharmaceuticals. With a focus on innovative solutions, her work has garnered attention in both academic and medical communities.
Latest Patents
Maria Karmella Apaya holds 2 patents that showcase her groundbreaking research. Her first patent, titled "Use of Extract in the Treatment of Breast Cancer," describes a method for treating breast cancer and its metastasis. This method involves administering an effective amount of extract, potentially combined with a pharmaceutically acceptable carrier or excipient. Her second patent, "Galactolipids-Enriched Plant Extracts and the Uses Thereof," details a galactolipids-enriched plant extract prepared from specific plant samples. This invention includes compositions aimed at protecting or treating acute fulminant hepatitis, sepsis, and skin whitening, utilizing bioactive ingredients derived from the plant extracts.
Career Highlights
Maria Karmella Apaya is affiliated with Academia Sinica, a prestigious research institution in Taiwan. Her work has not only advanced scientific knowledge but also provided practical applications in healthcare.
Collaborations
Some of her notable coworkers include Lie-Fen Shyur and Meng-Ting Chang, who have contributed to her research endeavors.
Conclusion
Maria Karmella Apaya's innovative work in cancer treatment and plant extracts highlights her role as a leading inventor in her field. Her patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
